1
|
Eggers H, Tiemann ML, Peters I, Kuczyk MA, Grünwald V, Ivanyi P. Prognostic Impact of Lymphnode Metastases in Patients with Metastatic Renal Cell Carcinoma. KIDNEY CANCER 2021. [DOI: 10.3233/kca-210129] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND: Lymphnode metastases (LMN) in metastatic renal cell carcinoma (mRCC) has been associated with an unfavourable prognosis. However, the prognostic impact of LNM in mRCC in context of other solid organ metastases and throughout subsequent therapeutic lines is not well-defined. OBJECTIVE: This retrospective single-center analysis was designed to elucidate the impact of LNM in the context of other solid organ metastases and throughout subsequent therapeutic lines. METHODS: mRCC patients (pts) at our center were analysed (observation period, 04/00-03/16). Primary endpoint was overall survival (OS) and the impact of line of therapy as a co-variate. Pts were grouped into: with LNM [LNM(+)], without LNM [LNN(–)]. Subgroup analyses of LNM(+) was performed including the subgroup LNM(+) and other solid organ metastases [LNM(+) other] and LNM(+) without other solid organ metastases [LMN(+) only]. RESULTS: 383/401 mRCC pts were eligible. 318 (83.2%), 230 (60.1%) and 154 (40.5%) pts received 1stL, 2ndL and 3rdL medical treatment, respectively. In the overall population OS was 40.1 months (95%CI: 32.7–47.4), with superior OS in LNM(–) compared to LNM(+) pts (log rank, HR 1.7, 95%-CI 1.3-2.2, p < 0.001). This effect was maintained across lines of therapies. LNM(+) only had a similar risk of death as LNM(–) pts (HR 1.2, 95%-CI 0.8–2.0, p = 0.4), while the risk of death was significantly increased for LNM(+) other compared to LNM(–) (HR 1.9, 95%-CI 1.5–2.6, p < 0.001). CONCLUSION: LNM(+) in mRCC is associated with a poor OS. However, impaired OS in LNM(+) might be associated with the presence of other solid organ metastases rather than with the existence of LNM alone. Further studies are warranted to support this hypothesis.
Collapse
Affiliation(s)
- Hendrik Eggers
- Deparment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
| | - Marie Luise Tiemann
- Deparment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
| | - Inga Peters
- Department of Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany
| | | | - Viktor Grünwald
- Deparment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
- Interdisciplinary GU Oncology, West-German Cancer Center Essen, University Hospital Essen, Essen, Germany
- Interdisciplinary Working Group Renal Cell Carcinoma (IAGN), Working Group Internal Oncology of the German Cancer Society, Berlin, Germany
| | - Philipp Ivanyi
- Deparment of Hematology, Hemostaseology, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
- Interdisciplinary Working Group Renal Cell Carcinoma (IAGN), Working Group Internal Oncology of the German Cancer Society, Berlin, Germany
- Immuno-Cooperative-Oncology Working Group (ICOG), Comprehensive Cancer Center Lower Saxony, Hannover, Germany
| |
Collapse
|
2
|
Di Virgilio F, Belluzzi E, Santos M, Caraty J, Bongartz A, Deneuche A. Practice patterns about the role of palliation in veterinary surgical oncology. Vet Comp Oncol 2021; 19:750-758. [PMID: 34260820 DOI: 10.1111/vco.12754] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2020] [Revised: 06/29/2021] [Accepted: 07/12/2021] [Indexed: 11/29/2022]
Abstract
Whether surgical palliative therapy is appropriate for oncologic veterinary patients is an increasing concern as pet age increases because of improved care. In this study, an online survey (available for 30 days), comprising 100 questions with structured response options, was administered to 492 diplomates of the European College of Veterinary Surgeons (ECVS). The survey queried the technical, ethical, social, medical, and financial aspects of surgical palliative therapy for oncologic veterinary patients. Responses were received from 155 ECVS diplomates (31.5%, n = 155/492). Palliative surgery was a relatively common intervention in veterinary oncology, with 50% of respondents (n = 77.5/155) indicating that 75%-100% of oncological surgeries performed were palliative. The presence of metastasis was judged as a key determinant when deciding to perform palliative oncological surgery by 41% of the respondents (n = 63.5/155). The survey revealed that the most commonly performed procedures in palliative oncological surgery were marginal resection, debulking, and amputation. In contrast to human medicine, palliative limb-sparing surgery, stent placement, and embolization were rarely used in veterinary settings, mainly because of a general lack of expertise among veterinarians, elevated costs, and recourse to euthanasia. Taken together, the survey results highlight the need for appropriate guidelines in the field of oncological surgery. To establish general guidelines and direct veterinarians towards the most appropriate judgement, understanding how and what veterinary surgeons manage palliative oncological surgery and how they perceive the main ethical, social, medical, and financial concerns are essential. Such guidelines will lead to better care for ailing animals and will facilitate the path to healing for owners.
Collapse
Affiliation(s)
| | - Elena Belluzzi
- Department of Surgery, Clinique Vétérinaire Bongartz, Liège, Belgium
| | - Marisa Santos
- Department of Surgery, Clinique Vétérinaire Vet24, Marcq en Baroeul, France
| | - Johan Caraty
- Department of Surgery, Clinique Vétérinaire Bongartz, Liège, Belgium
| | | | - Aymeric Deneuche
- Department of Surgery, Clinique Vétérinaire Vet24, Marcq en Baroeul, France
| |
Collapse
|
3
|
Hawley A, Davis S, Illum L. Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics. Adv Drug Deliv Rev 1995. [DOI: 10.1016/0169-409x(95)00045-9] [Citation(s) in RCA: 132] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
4
|
Abstract
Appropriate clinical management of the regional lymph node remains controversial. This article briefly reviews the anatomy and physiology of the lymphatic system, pathophysiology of lymphatic metastases, and some guidelines and rationale for clinical management.
Collapse
Affiliation(s)
- S D Gilson
- Sonora Veterinary Surgery and Oncology, Scottsdale, Arizona, USA
| |
Collapse
|